Patrick Forrest

Q: What Schools Are Affiliated With Patrick Forrest

Patrick Forrest is affiliated with the following schools: University of St Andrews, University of Oxford, University of Edinburgh, University of Glasgow, Royal College of Science and Technology

Patrick Forrest's AcademicInfluence.com Rankings

Patrick Forrest

Medical

#1783

World Rank

#2159

Historical Rank

Surgery

#168

World Rank

#215

Historical Rank

medical Degrees

Patrick Forrest

Philosophy

#10017

World Rank

#13689

Historical Rank

Logic

#6958

World Rank

#8534

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Patrick Forrest's Degrees

Bachelors Medicine University of Oxford

Why Is Patrick Forrest Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sir Andrew Patrick McEwen Forrest was a Scottish surgeon. After qualifying in medicine from the University of St Andrews and completing a Fellowship at the Mayo in Rochester, Minnesota, he took up surgical posts first in Glasgow, then in Wales, followed by a position as Regius Chair of Clinical Surgery at Edinburgh.

(See a Problem?)

Patrick Forrest's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial (1996) (407)
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening (1999) (385)
ALLELE LOSS ON SHORT ARM OF CHROMOSOME 17 IN BREAST CANCERS (1988) (281)
Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial (1995) (272)
Oestrogen receptors and breast cancer: Current status (1980) (209)
Scottish adjuvant tamoxifen trial: a randomized study updated to 15 years. (2001) (190)
The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: A controlled randomized trial (1985) (177)
Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group. (1996) (172)
Significance of aromatase activity in human breast cancer. (1982) (163)
The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. (1994) (138)
Oestradiol synthesis from C19 steroids by human breast cancers. (1976) (130)
Primary systemic therapy for operable breast cancer. (1991) (113)
p53 gene mRNA expression and chromosome 17p allele loss in breast cancer. (1990) (111)
ŒSTRADIOL SYNTHESIS BY A HUMAN BREAST CARCINOMA (1974) (102)
The Edinburgh randomised trial of screening for breast cancer: description of method. (1984) (102)
THE HISTAMINE-INFUSION TEST. (1964) (101)
Prolactin (1973) (98)
Long‐term survivors after breast cancer (1985) (96)
Simple Mastectomy and axillary Node Sampling (Pectoral Node Biopsy) in the Management of Primary Breast Cancer (1982) (95)
Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. (1996) (95)
Classification of human breast cysts according to electrolyte and androgen conjugate composition. (1983) (91)
Breast Volumes in Cancer of the Breast (1974) (90)
Mucous change in the human duodenum: A light and electron microscopic study and correlation with disease and gastric acid secretion (1974) (87)
Plasma prolactin in breast cancer. (1973) (87)
Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management. (1985) (83)
A HUMAN TUMOUR MODEL (1986) (78)
A human tumor model (1986) (76)
Steroid metabolism by human breast and rat mammary carcinomata. (1974) (75)
COMPARATIVE PATHOLOGY OF PREVALENT AND INCIDENT CANCERS DETECTED BY BREAST SCREENING Edinburgh Breast Screening Project (1986) (74)
Mammary duct ectasia (1983) (70)
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy. (1997) (69)
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer. (1989) (65)
Oestrogen receptors, cellularity, elastosis and menstrual status in human breast cancer. (1978) (58)
CIRCULATING HORMONE CONCENTRATIONS IN WOMEN WITH BREAST CANCER (1976) (58)
Short Communications. Steroid metabolism by human breast tumours (1970) (57)
RELATION BETWEEN IMMUNOCYTOCHEMICAL ESTIMATION OF OESTROGEN RECEPTOR IN ELDERLY PATIENTS WITH PRIMARY BREAST CANCER AND RESPONSE TO TAMOXIFEN (1989) (57)
Pituitary radon implant for advanced cancer. (1956) (51)
Plasma dehydroepiandrosterone sulphate levels in patients with benign and malignant breast disease. (1972) (50)
Pituitary-radon implant for breast cancer. (1955) (50)
Prognostic significance of oestrogen and progestogen receptor activities in breast cancer (1987) (50)
Basal prolactin blood levels in three strains of rat with differing incidence of 7,12-dimethylbenz(a)anthracene induced mammary tumours. (1973) (48)
Radio‐active implantation of the pituitary (1959) (48)
Oestradiol synthesis by a human breast carcinoma. (1974) (46)
Plasma prolactin and breast cancer (1974) (46)
The morbidity of mastectomy. (1972) (45)
Mobile breast screening: factors affecting uptake, efforts to increase response and acceptability. (1990) (45)
Localization and excision of occult breast lesions (1983) (42)
Does the oestrogen receptor concentration of a breast cancer change during systemic therapy? (1990) (41)
Pathology characteristics that optimize outcome prediction of a breast screening trial (2000) (40)
Reproducibility of measurements of oestrogen-receptor concentration in breast cancer. (1977) (40)
DNA analysis of breast tumour fine needle aspirates using flow cytometry. (1987) (39)
The inhibiting effect of epinephrine and norepinephrine on secretion induced by histamine in separated pouches of dogs. (1954) (38)
Benign and Malignant Breast Disease in South Wales: A Study of Urinary Steroids (1970) (36)
The Effect of Long Term Phenothiazine Therapy on Plasma Prolactin (1975) (35)
Metabolism of androgens by human breast tissue. (1973) (35)
Oestrogen receptors and the response to endocrine therapy in advanced breast cancer. (1978) (33)
The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy. (1988) (33)
CYCLICAL BREAST PAIN — SOME OBSERVATIONS AND THE DIFFICULTIES IN TREATMENT (1992) (31)
Coarse mucosal folds in the duodenum. (1968) (30)
The Measurement of Gastric Acid (1965) (29)
The search for occult metastases in breast cancer: does it add to established staging methods? (1980) (29)
Screw-implantation of the pituitary with yttrium-90. (1958) (29)
The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer. (1980) (29)
Androgen conjugates in human breast cyst fluids. (1982) (26)
Oestrogen receptor activity and endocrine status in DMBA-induced rat mammary tumours. (1977) (26)
Interval cancers and sensitivity in the screening centres of the UK trial of early detection of breast cancer. (1993) (26)
Steroid metabolism by human breast tumours. (1970) (26)
Simple versus radical mastectomy. Preliminary report of the Cardiff breast trial. (1973) (26)
Progesterone cream for cyclic breast pain. (1989) (26)
Plasma-growth-hormone levels in untreated acromegaly and after radioactive implants into the pituitary. (1965) (24)
The secretion of cortisol and corticosterone by the human adrenal cortex. (1957) (24)
PREDICTION OF AXILLARY METASTASES IN BREAST CANCER BY LYMPHOSCINTIGRAPHY (1980) (24)
South-east Scottish trial of local therapy in node negative breast cancer (1994) (23)
Accuracy of Screening Methods for the Diagnosis of Breast Disease (1970) (23)
URINARY ŒSTROGENS AFTER ENDOCRINE ABLATION (1960) (23)
THE SIGNIFICANCE OF THE RADIOLOGICAL FINDING OF COARSE MUCOSAL FOLDS IN THE DUODENUM. (1964) (22)
Breast cancer: the decision to screen. (1991) (21)
Therapy of breast cancer (1978) (20)
Clinical assessment of tumour size in primary breast carcinoma. (1984) (19)
Acid secretion in symptomatic sliding hiatus hernia. (1967) (19)
Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions (1981) (19)
Factors affecting testosterone metabolism by human breast tissues. (1978) (19)
Relation between apocrine differentiation and receptor status, prognosis and hormonal response in breast cancer. (1990) (18)
Effect of postganglionic sympathectomy on canine gastric secretion. (1954) (16)
The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer. (1979) (16)
CUSHING'S SYNDROME WITH ATYPICAL BIOCHEMICAL RESULTS. (1964) (16)
Mammography screening for breast cancer. (1990) (16)
COMMENT ON: QUANTITATIVE INTERPRETATION OF AGE-SPECIFIC MORTALITY REDUCTIONS FROM THE SWEDISH BREAST CANCER-SCREENING TRIALS. AUTHORS'S REPLIES (1996) (15)
Randomised study of axillary clearance versus four node sampling (2001) (15)
Steroid metabolism and oestrogen receptors in human breast carcinomas. (1981) (15)
Buffering capacity of food in relation to stimulation of gastric secretion. (1968) (15)
Management of Pituitary Tumours (1965) (14)
Acquired renal disease simulating diabetes insipidus. (1955) (14)
Which patients are cured of breast cancer? (1984) (14)
Needle aspiration of breast cysts. (1975) (14)
Response of plasma prolactin and growth hormone to insulin hypoglycaemia. (1972) (14)
Effects of histamine acid phosphate and pentagastrin on gastric secretion in normal human subjects (1970) (13)
Acid secretion from canine separated fundic pouches. (1967) (13)
URINARY STEROID PATTERNS IN BREAST CANCER (1957) (12)
A controlled trial of conservative treatment for early breast cancer. (1970) (12)
The short pentagastrin test in the investigation of gastric disease. (1969) (12)
Beneficial response to pituitary ablation following aminoglutethimide (1986) (12)
Hormonal Influences in Breast Cancer (1971) (12)
Lymphoscintigraphy cannot diagnose breast cancer (1981) (11)
Preliminary report of a controlled trial in advanced breast cancer comparing tamoxifen with conventional hormone therapy. (1976) (11)
Effect of sympathectomy and vagotomy on the inhibition by insulin of histamine-induced secretion in separated (Heidenhain) canine pouches. (1954) (11)
The Cardiff local therapy trial — results at 20 years (1994) (11)
Staples or sutures for mastectomy wounds? A randomised trial. (1983) (10)
Urinary aetiocholanolone in patients with early breast cancer from South East Scotland and South Wales. (1975) (9)
The Effect of an Adrenal Inhibitor (SU 4885) on Gastric Secretion in Dogs (1960) (9)
Early pituitary implantation with yttrium-90 for advanced breast cancer. (1969) (9)
Oestrogen receptors and primary breast cancer. (1982) (8)
The inhibitory action of a locally applied antihistamine on canine gastric secretion induced by peripheral parasympathetic stimulation (1956) (8)
Fundamentals of Surgical Practice: Principles of cancer management (2006) (8)
Progestagens and advanced breast cancer. (1971) (8)
Preoperative Assessment and Staging of Breast Cancer: Preliminary Communication 1 (1980) (8)
The treatment of duodenal ulcer by gastroenterostomy, gastroenterestomy and vagotomy and partial gastrectomy. (1958) (8)
Screening for breast cancer: the UK scene (1989) (8)
Steroid Metabolism in Human Breast Cancer (1971) (8)
Breast cancer symposium. Points in the practical management of breast cancer. (1969) (8)
ŒSTROGEN IN BREAST FLUID (1977) (8)
Breast cancer screening and management (1999) (7)
Urinary 17-Ketosteroids and their Fractions in Women with Breast Cancer Treated by Endocrine Surgery (1960) (7)
Cancer of the Breast Early Diagnosis (1970) (7)
Effect of antral acidification on acid secretion induced by meat and pentagastrin. (1969) (7)
The use of cerebral computer assisted tomography as a staging investigation of patients with carcinoma of the breast and malignant melanoma. (1980) (7)
Oestrogen in breast fluid. (Letter) (1977) (6)
Oestrogen in breast fluid. (1977) (6)
Prolactin and breast cancer. (1973) (6)
Screening and breast cancer incidence. (1990) (6)
The relevance of control histology in oestrogen receptor estimation. (1987) (6)
Proceedings: inhibition of human gastric secretion by orally or intravenously administered prostaglandin 16, 16 dimethyl-E2 methyl ester. (1973) (6)
The surgeon's role in breast screening (1989) (6)
Prognostic factors in breast cancer : proceedings of first Tenovus Symposium, Cardiff, 12th-14th April 1967 (1968) (6)
Effects of Histamine Acid Phosphate and Pentagastrin on Gastric Secretion in Normal Human Subjects and in Patients with Various Gastroduodenal Diseases (1971) (6)
Assessment of non‐palpable mammographic abnormalities: Comparison between screening and symptomatic clinics (1992) (6)
“Superstaging” in breast cancer—A correlation of lymph node histology and investigations designed to detect occult metastatic disease (1977) (5)
Pituitary function after yttrium implants as measured by plasma growth hormone levels. (1971) (5)
Selection of local therapy for primary breast cancer by lower axillary node histology. (1980) (5)
Beatson: hormones and the management of breast cancer. (1982) (5)
Advances in the management of carcinoma of the breast. (1986) (5)
Aminoglutethimide and advanced breast cancer [proceedings]. (1980) (5)
Radioactive implants of the pituitary for endocrine disease. (1970) (4)
Primary cancer of the breast—indications for therapy (1974) (4)
A controlled clinical trial to compare transethidal hypophysectomy with yttrium implant of the pituitary in the treatment of advanced breast cancer. (1969) (4)
Screening for breast cancer in the under 50s (1993) (4)
Effect of Cortisone on Oestrogens in the Urine of Patients following Endocrine Ablation (1959) (4)
Mastectomy with primary reconstruction (1984) (4)
The differing predictive values of oestrogen receptor assays for large breast cancers. (1992) (4)
MIB-1 in relation to tumour response and survival in patients with breast cancer treated with primary systemic therapy (1999) (4)
"Closed" biopsy for breast cancer. (1980) (4)
Human breast carcinomata in organ culture: the effect of hormones. (1976) (4)
48. Long-term follow-up of neo-adjuvant therapy in operable breast cancer — an update of the original Edinburgh series (1995) (4)
Screening for breast cancer. (1990) (4)
A question that will not go away: at what age should mammographic screening begin? (1995) (3)
Tamoxifen and mastectomy for elderly patients with operable breast cancer. (1988) (3)
405 Androgen receptors in human breast cancers (1983) (3)
Site size and significance of palpable metastatic and 'reactive' nodes in operable breast cancer. (1982) (3)
The advantage of adrenaline in local and general anaesthetic breast biopsy. (1983) (3)
Comparison of the gastric secretory responses following the administration of histamine acid phosphate and pentagastrin by separate continuous intravenous infusions or by a step-test method. (1970) (3)
Hormone Receptors and Breast Cancer—an Occasional Survey (1983) (3)
A clinical trial of treatment in early breast cancer. (1973) (3)
Sex-hormone-binding globulin and oestrogen receptors. (1981) (3)
Operative aid to combined synchronous mastectomy and latissimus dorsi breast reconstruction. (1985) (3)
The effect of antral acidification on acid secretion stimulated by pentagastrin (1973) (3)
Pituitary ablation by yttrium-90. (1974) (3)
The surgeon and breast cancer 1987. (1988) (3)
Metabolic response to surgery in totally adrenalectomised women. (1957) (2)
Fifteenth Lister Memorial lecture: rationalization of the management of breast cancer. (1971) (2)
Simple mastectomy and pectoral node biopsy: The Cardiff-St. Mary's trial (1977) (2)
Antral and duodenal acidification. Effect on pentagastrin-stimulated acid secretion in the dog. (1974) (2)
Primary treatment in breast cancer. (1991) (2)
Aminoglutethimide vs. surgical adrenalectomy in breast cancer. (1982) (2)
Surgical Endocrine Ablation for Advanced Breast Cancer (1957) (2)
Ultramicrochemical studies on the site of formation of dehydroepiandrosterone sulphate in the adrenal cortex. (1968) (2)
Primary systemic therapy for breast cancer. (1991) (2)
Adjuvant therapy with 5-fluorouracil for breast cancer of likely poor prognosis: 15-year results of a randomized trial. (1995) (2)
Pituitary function and clinical response in breast cancer patients after yttrium implantation. (1979) (2)
Needle Aspiration ofBreast Cysts (1975) (2)
Tumour steroid hormone synthesis and estrogen receptor status in breast cancer patients (1981) (2)
Proceedings: Chlorpromazine stimulation of prolactin secretion: a test of pituitary function. (1974) (2)
C19-steroid biosynthesis in the human adrenal gland. (1971) (2)
AXILLARY SAMPLING IN BREAST CANCER (1982) (2)
Oestrogen receptors and survival in early breast cancer. (1982) (2)
Evaluation of treatment of primary cancer of the breast. (1967) (2)
The role of the antrum in determining the acid secretory response to meals to different consistency. (1975) (2)
Treatment of advanced breast cancer by yttrium-90 implantation of the pituitary. (1959) (2)
The effect of node sample size on the histological node status in patients with operable breast cancer. (1982) (2)
Treatment of cancer of the breast. (1962) (1)
Gastric acid production in jaundice. (1968) (1)
Gastric freezing for duodenal ulcer (1965) (1)
Steroid interconversions by metastatic deposits of a human bronchogenic carcinoma. (1976) (1)
Cellularity and the quantitation of estrogen receptors (1982) (1)
Breast cancer: the way ahead. (1976) (1)
THE EDINBURGH RANDOMIZED TRIAL OF BREAST-CANCER SCREENING - RESULTS AFTER 10 YEARS OF FOLLOW-UP 10 (2007) (1)
Breast cancer—advances in research and treatment. Edited William L. McGuire. 227×150 mm. Pp. 383+xiv. Illustrated. 1978. Edinburgh: Churchill Livingstone. £d18.00 (1979) (1)
Comparison of general and local anaesthesia for biopsy of breast lumps. (1983) (1)
Discussion on Hypophysectomy for Cancer (1957) (1)
Surgical research: a survey. (1981) (1)
Release of an immunologically active humoral factor from the isolated perfused thymus. (1974) (1)
A pilot scheme for medical closed-circuit television. (1969) (1)
Urinary steroids and breast disease. (1969) (1)
In vitro effects of oestrogen on testosterone metabolism by human breast cancers. (1978) (1)
Advances in the Management of Breast Cancer: Physician and Surgeon (1981) (1)
Scottish randomised controlled trial of conservation therapy for breast cancer (1996) (1)
Prognosis of cancer of the breast. (1971) (1)
A COMPARISON IN VITRO OF THE CONVERSION OF PREGNENOLONE SULPHATE AND PREGNENOLONE TO STEROID HORMONES BY TISSUE FROM A CLEAR CELL ADENOMA OF THE ADRENAL GLAND (1967) (1)
Pituitary function tests after radioactive implantation of the pituitary. (1960) (1)
PITUITARY IMPLANTATION FOR PITUITARY TUMOURS (1965) (1)
Steroid Metabolism and Oestrogen Receptors in Human Breast Carcinomas (1982) (1)
PLASMA SEX HORMONE BINDING GLOBULIN AND TUMOUR OESTROGEN RECEPTOR STATUS IN BREAST CANCER PATIENTS (1981) (1)
Testosterone metabolism by breast tumours. (1972) (1)
Steriod metabolism by human normal thyroid, nodular goitre and thyroid cancer. (1974) (1)
Therelevance ofcontrol histology inoestrogen receptor estimation (1987) (1)
6th International Nottingham Breast Cancer Conference 1999 (1999) (1)
WHO NEEDS STEROID RECEPTOR ASSAYS? (1989) (1)
Conservative management of breast cancer: a review of British controlled trials. (1980) (1)
Induction of tumour aromatase following treatment with aminoglutethimide-hydrocortisone in patients with breast cancer (1987) (1)
High-Risk breast cancer: Diagnosis (1992) (1)
THE USE OF RADIOACTIVE YTTRIUM FOR DESTRUCTION OF THE PITUITARY GLAND. (1964) (1)
Lymphocyte output by the isolated perfused rabbit thymus. (1974) (1)
Effects of Prolactin upon C19 Steroid Metabolism by Rat Mammary Carcinoma (1974) (1)
Screening for breast cancer: the UK scene. The 69th Mackenzie Davidson memorial lecture. (1989) (1)
Immunosuppression with cell membrane extracts. (1970) (0)
Breast cancer and the Royal College of Surgeons of Edinburgh. (1984) (0)
The effect of chemotherapy on pituitary function in patients with advanced breast cancer. (1979) (0)
ENDOCRINE SURGERY FOR ADVANCED BREAST CANCER. (1964) (0)
Breast cancer (1985) (0)
Endocrine Control of Breast Cancer (1970) (0)
Oestrogen receptor activity in human breast tumours. (Abstract only) (1976) (0)
Effects of drugs associated with hyperprolactinemia on plasma steroids and on steroid receptors and metabolism in human breast cancer (2005) (0)
Axillary lymphoscintigraphy (1981) (0)
Accuracy of screening methods for breast disease. (1970) (0)
Effect of denervation of pyloric antrum on the gastric secretory response to food. (1975) (0)
Thediffering predictive values ofoestrogen receptor assays forlarge breast cancers (1992) (0)
Gastric secretion in atrophic mucosal states. (1968) (0)
Proceedings: Pituitary function after yttrium-90 hypophysectomy. (1974) (0)
Therole oftheantrumindetermining theacid secretory responsetomeals ofdifferent consistency (1975) (0)
A simple method of implanting radon seeds into the pituitary gland in the treatment of advanced breast cancer. (1956) (0)
[Treatment of breast cancer (author's transl)]. (1977) (0)
Fast Neutrons in the Treatment of Cancer M. Catterall and D. Bewley. 235 × 158 mm. Pp. 394+viii. Illustrated. 1979. London: Academic. £22.40 (1981) (0)
Growth-hormone test of residual pituitary function. (1969) (0)
Aspiration cytology of the breast. Hubert Schöndorf (translated by Volker Schneider). 245×170 mm. Pp. 141+vii. 1978. Eastbourne: Holt–Saunders. £18.25 (1979) (0)
Advances in Endocrine Surgery [Abridged] (1970) (0)
UK BREAST SCREENING PROGRAM. AUTHOR REPLY (1991) (0)
Management of Early Carcinoma of the Breast [Abridged] (1970) (0)
Explorer THE EDINBURGH RANDOMIZED TRIAL OF BREAST-CANCER SCREENING-RESULTS AFTER 10 YEARS OF FOLLOW-UP (2007) (0)
Effect of hypophysectomy on the growth hormone response to insulin-induced hypoglycaemia. (1973) (0)
Proceedings: The effects of fentazin on androgen metabolism in DMBA induced rat adenocarcinomata. (1974) (0)
Yttrium implant for advanced breast cancer. (1977) (0)
Early breast cancer: Its history and results of treatment, volume 5. experimental biology and medicine. Carl M. Mansfield. 225 × 155 mm. Pp. 129. 1976. Basle: Karger. No price given (1977) (0)
Androgen metabolism in human neoplastic and normal breast tissue (1973) (0)
ACCESSORY ADRENOCORTICAL FUNCTION AFTER ADRENALECTOMY IN PATIENTS WITH BREAST CANCER (1961) (0)
The effect of antral acidification on acid secretion stimulated by pentagastrin. (1973) (0)
The Early Management of Breast Cancer (1967) (0)
Clinical studies in advanced breast cancer. (1967) (0)
The Management of Operable Breast Cancer in Scotland Surgeons' Opinions (1994) (0)
Diagnosis of cancer of the breast with special reference to mammography and thermography. (1969) (0)
Consent to mastectomy (1980) (0)
Treatment of early breast cancer. (1978) (0)
The patient's subjective attitude towards screening for breast cancer. Should screening be extended to other forms of cancer? (1980) (0)
Lister oration. Breast cancer: 121 years on. (1989) (0)
Steroidogenesis in human breast cancer, benign breast disease and normal breast tissue (1973) (0)
The Diagnosis of Gastric Cancer (1960) (0)
Release of gastrin by vagal stimulation in the acid secretory response to food. (1976) (0)
The effect of antral acidification on gastric secretion stimulated by pentagastrin. (1972) (0)
Steroidogenesis in human and rat mammary adenocarcinoma. (1972) (0)
AMINOGLUTETHIMIDE IN BREAST CANCER (1978) (0)
TREATMENT OF EARLY BREAST CANCER (1978) (0)
Perspectives in oncological surgery. (1978) (0)
A light and electron microscopic study of the changes in the duodenal mucosa induced by sustained pentagastrin stimulation of gastic acid secretion in young rats. (1975) (0)
Breast cancer 100 years on--what we have learnt! (1996) (0)
The inhibitory influence of the pyloric antrum on gastric secretion in dogs. (1976) (0)
Treatment of primary breast cancer: an overview. (1977) (0)
The problem of management of breast cancer. (1979) (0)
Breast localization biopsy. (1982) (0)
Book Review: Carcinoma of the Breast (1969) (0)
Bile reflux in active and healed gastric ulcer. (1970) (0)
THE IN VITRO METHOD FOR INVESTIGATION OF STEROID BIOSYNTHETIC PATHWAYS — A CRITICAL STUDY (1967) (0)
Cytotoxic or endocrine primary systemic therapy (PST) for operable large primary breast cancer (1991) (0)
The surgeon and cancer research. Bruce Memorial Lecture. (1971) (0)
Progress in the treatment of breast cancer—Introduction (1977) (0)
Carcinoma of the Breast. (1969) (0)
Early pituitary implantation for advanced breast cancer. (1969) (0)
17. Scottish trial of conservation therapy (1995) (0)
Screening for breast cancer in the under 50s. (1993) (0)
ENDOCRINE TREATMENT OF BREAST CANCER. (1965) (0)
Androgen metabolism in human neoplastic and normal breast tissue. (1973) (0)
UK Breast Screening Program (1991) (0)

This paper list is powered by the following services:

Other Resources About Patrick Forrest

en.wikipedia.org

What Schools Are Affiliated With Patrick Forrest?

Patrick Forrest is affiliated with the following schools:

Patrick Forrest's Academic­Influence.com Rankings

Patrick Forrest's Degrees

Why Is Patrick Forrest Influential?

Patrick Forrest's Published Works

Published Works

Other Resources About Patrick Forrest

What Schools Are Affiliated With Patrick Forrest?

Patrick Forrest's AcademicInfluence.com Rankings